KV completes debt financing

KV Pharmaceutical Co. (NYSE:KVA), St. Louis, Mo. Business: Drug delivery, Generics Date completed: 9/14/10 Type: Debt financing Raised: $20 million Investor: U.S. Healthcare Note: The secured loan bea...